Inventor · disambiguated record
Siobhan Fogarty
Also filed as: FOGARTY SIOBHAN · FOGARTY SIOBHAN J
3 granted patents·9 pending applications·4 citations·filing 2003–2022
57Inventor score
Files withTRIMEL PHARMACEUTICALS CORP3TONIX Pharmaceuticals Holding Corp2ACERUS BIOPHARMA INC1ACERUS PHARMACEUTICALS CORP1ACERUS PHARMACEUTICALS SRL1
Top patents by PatentIndex Score
12 records- 0175US10111888B2Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderACERUS PHARMACEUTICALS SRL·Filed 2015·Granted Oct 30, 2018·2 cites·12 claims
- 0271US9757388B2Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gelsKREPPNER WAYNE·Filed 2012·Granted Sep 12, 2017·2 cites·42 claims
- 0354US2024165126A1Tianeptine oxalate and naloxone combination for the treatment of major depressive disorderTONIX Pharmaceuticals Holding Corp·Filed 2022·Application pending·0 cites
- 0451US10668084B2Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderACERUS BIOPHARMA INC·Filed 2015·Granted Jun 2, 2020·0 cites·43 claims
- 0551US2013040922A1Intranasal 0.45% and 0.48% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderTRIMEL PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
- 0651US2022016268A1Skin-based testing for detection of cell-mediated immune responses to sars-cov-2TONIX Pharmaceuticals Holding Corp·Filed 2021·Application pending·0 cites
- 0751US2013045958A1Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderTRIMEL PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
- 0846US2016250228A1Intranasal 0.45% and 0.48% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderACERUS PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
- 0946US2004137060A1Enalapril microspheres, dosage forms and chronotherapeutic methods based thereonFiled 2003·Application pending·0 cites
- 1042US2013040923A1Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderTRIMEL PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
- 1142US2003165566A1Sedative non-benzodiazepine formulationsFiled 2003·Application pending·0 cites
- 1238US2022153780A1Salt forms of s-(n, n-diethylcarbamoyl)glutathioneTONIX PHARMA HOLDINGS LTD·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →